| Patent | Date |
|---|
Radioligands For Imaging The Id01 Enzyme
App 20220305144 - Donnelly; David J. ; et al. | 2022-09-29 |
AGONISTS OF ROR GAMMAt
App 20220306630 - Harikrishnan; Lalgudi S. ; et al. | 2022-09-29 |
Anti-pd-1 Antibody In Combination With An Anti-cd30 Antibody In Cancer Treatment
App 20220298243 - FARSACI; Benedetto ; et al. | 2022-09-22 |
PSGL-1 Antagonists and Uses Thereof
App 20220298258 - Johnston; Robert J. ; et al. | 2022-09-22 |
Biaryl Dialkyl Phosphine Oxide Fpr2 Agonists
App 20220298186 - Shirude; Pravin Sudhakar ; et al. | 2022-09-22 |
Process For Preparing Carbamoyloxymethyl Triazole Cyclohexyl Acid Compounds
App 20220298122 - Fox; Richard J. ; et al. | 2022-09-22 |
Methods Of Treating Prostate Cancer
App 20220296574 - Malatesta; Martina ; et al. | 2022-09-22 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 11,447,449 - Balog , et al. September 20, 2 | 2022-09-20 |
Spiroheptanyl hydantoins as rock inhibitors
Grant 11,447,487 - Vokits , et al. September 20, 2 | 2022-09-20 |
Fibronectin based scaffold proteins
Grant 11,447,538 - Lipovsek , et al. September 20, 2 | 2022-09-20 |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
Grant 11,447,475 - Cheng , et al. September 20, 2 | 2022-09-20 |
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
Grant 11,447,775 - Olson , et al. September 20, 2 | 2022-09-20 |
Substituted indole compounds useful as inhibitors of TLR7/8/9
Grant 11,447,466 - Dyckman , et al. September 20, 2 | 2022-09-20 |
Substituted Benzimidazolone Compounds
App 20220289739 - DYCKMAN; Alaric J. ; et al. | 2022-09-15 |
Aminoimidazopyridazines as kinase inhibitors
Grant 11,440,913 - Mertzman , et al. September 13, 2 | 2022-09-13 |
Treatment Of Pd-l1-positive Melanoma Using An Anti-pd-1 Antibody
App 20220281974 - YANG; Arvin | 2022-09-08 |
Antibodies Against Mica And/or Micb And Uses Thereof
App 20220281980 - KUHNE; Michelle Renee ; et al. | 2022-09-08 |
Bicyclic Heterocyclic Compounds Useful As Irak4 Inhibitors
App 20220281844 - Ahmad; Saleem ; et al. | 2022-09-08 |
Fast-off rate serum albumin binding fibronectin type III domains
Grant 11,434,275 - Krystek, Jr. , et al. September 6, 2 | 2022-09-06 |
Fibronectin Binding Domains With Reduced Immunogenicity
App 20220275535 - DAVIS; Jonathan ; et al. | 2022-09-01 |
Combination Of Tim-4 Antagonist And Pd-1 Antagonist And Methods Of Use
App 20220275091 - DOYLE; Sean E. ; et al. | 2022-09-01 |
Cyclic dinucleotides as anticancer agents
Grant 11,427,610 - Fink , et al. August 30, 2 | 2022-08-30 |
6-azaindole compounds
Grant 11,427,580 - Dyckman , et al. August 30, 2 | 2022-08-30 |
Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation
App 20220267273 - DELMONTE; Albert J. ; et al. | 2022-08-25 |
Thienopyridinyl And Thiazolopyridinyl Compounds Useful As Irak4 Inhibitors
App 20220267348 - Ahmad; Saleem ; et al. | 2022-08-25 |
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl Compounds Useful As Irak4 Inhibitors
App 20220267335 - Wu; Hong ; et al. | 2022-08-25 |
Aryl and heteroaryl substituted indole compounds
Grant 11,420,958 - Dyckman , et al. August 23, 2 | 2022-08-23 |
Amide substituted indole compounds useful as TLR inhibitors
Grant 11,420,973 - Dyckman , et al. August 23, 2 | 2022-08-23 |
Method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids
Grant 11,421,278 - Carman , et al. August 23, 2 | 2022-08-23 |
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
Grant 11,421,034 - Lewis , et al. August 23, 2 | 2022-08-23 |
Methods Of Identifying A Subject Suitable For An Immuno-oncology (i-o) Therapy
App 20220259669 - SZABO; Peter M. ; et al. | 2022-08-18 |
Crystal Form Of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-- Yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide
App 20220259183 - Rosso; Victor W. | 2022-08-18 |
Tricyclic Heteroaryl Compounds Useful As Irak4 Inhibitors
App 20220259205 - Nair; Satheesh Kesavan ; et al. | 2022-08-18 |
Compounds useful as immunomodulators
Grant 11,414,418 - Yeung , et al. August 16, 2 | 2022-08-16 |
Immunomodulators
App 20220251141 - WANG; Tao ; et al. | 2022-08-11 |
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists
App 20220249443 - Cheng; Peter Tai Wah ; et al. | 2022-08-11 |
Anti-ctla4 Antibody Prodruggable (probody) At A Cdr Position
App 20220251206 - KRYSTEK JR.; Stanley R. ; et al. | 2022-08-11 |
Stabilized fibronectin based scaffold molecules
Grant 11,407,815 - Lipovsek August 9, 2 | 2022-08-09 |
Biarylmethyl heterocycles
Grant 11,407,733 - Priestley , et al. August 9, 2 | 2022-08-09 |
Fibronectin binding domains with reduced immunogenicity
Grant 11,408,093 - Davis , et al. August 9, 2 | 2022-08-09 |
Anti-GITR antibodies for cancer diagnostics
Grant 11,408,889 - Wang , et al. August 9, 2 | 2022-08-09 |
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
Grant 11,400,094 - Poudel , et al. August 2, 2 | 2022-08-02 |
Antibodies binding to ILT4
Grant 11,401,328 - Schebye , et al. August 2, 2 | 2022-08-02 |
Methods of minimizing glycoprotein agregation in CHO cell production
Grant 11,401,509 - Tian August 2, 2 | 2022-08-02 |
Antibody Compositions and Methods of Use Thereof
App 20220233693 - HUANG; Masano ; et al. | 2022-07-28 |
Methods Of Treating Tumors
App 20220233689 - Huang; Masano ; et al. | 2022-07-28 |
Crystalline Salt Forms Of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-- Yl)phenyl)amino)-n-(methyld3) Pyridazine-3-carboxamide
App 20220235039 - Roberts; Daniel Richard ; et al. | 2022-07-28 |
Cyclobutyl Carboxylic Acids As Lpa Antagonists
App 20220235027 - SHI; YAN ; et al. | 2022-07-28 |
Cell Localization Signature And Combination Therapy
App 20220233691 - SZABO; Peter ; et al. | 2022-07-28 |
Triazole Carboxylic Acids As Lpa Antagonists
App 20220235026 - Cheng; Peter Tai Wah ; et al. | 2022-07-28 |
Isoxazole Carboxylic Acids As Lpa Antagonists
App 20220235040 - Cheng; Peter Tai Wah ; et al. | 2022-07-28 |
Apelin receptor agonists and methods of use
Grant 11,390,616 - Meng , et al. July 19, 2 | 2022-07-19 |
Antibodies And Antigen Binding Peptides For Factor Xia Inhibitors And Uses Thereof
App 20220220220 - Luettgen; Joseph M. ; et al. | 2022-07-14 |
Methods Of Monitoring Cell Culture Media
App 20220220430 - ABADIAN; Pegah ; et al. | 2022-07-14 |
Methods For Regenerating Chromatography Resins
App 20220220423 - ANGELO; James ; et al. | 2022-07-14 |
Pyrazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
Grant 11,384,067 - Shi , et al. July 12, 2 | 2022-07-12 |
Methods for treating costimulation blockade resistant rejection
Grant 11,385,228 - Kirk , et al. July 12, 2 | 2022-07-12 |
Methods Of Treating Urothelial Carcinoma Using An Anti-pd-1 Antibody
App 20220213191 - TSCHAIKA; Marina | 2022-07-07 |
Angptl2 Antisense Oligonucleotides And Uses Thereof
App 20220213484 - ANDERSON; Brian R. ; et al. | 2022-07-07 |
Prodrug Compounds
App 20220213099 - DYCKMAN; Alaric J. ; et al. | 2022-07-07 |
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof
App 20220211812 - Dubowchik; Gene M. ; et al. | 2022-07-07 |
Substituted Amide Compounds Useful As Farnesoid X Receptor Modulators
App 20220213026 - Wacker; Dean A. ; et al. | 2022-07-07 |
Serum Albumin-binding Fibronectin Type Iii Domains
App 20220204589 - MITCHELL; Tracy S. ; et al. | 2022-06-30 |
Anti-nkg2a Antibodies And Uses Thereof
App 20220204618 - Bezman; Natalie ; et al. | 2022-06-30 |
Multicyclic compounds as farnesoid X receptor modulators
Grant 11,370,785 - Carpenter , et al. June 28, 2 | 2022-06-28 |
Methods Of Treating Tumor
App 20220195046 - LEI; Ming ; et al. | 2022-06-23 |
Ipilimumab Variants With Enhanced Specificity For Binding At Low Ph
App 20220193237 - LEE; Peter Sung Keun ; et al. | 2022-06-23 |
Anti-nkg2a Antibodies And Uses Thereof
App 20220195042 - Bezman; Natalie ; et al. | 2022-06-23 |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
Grant 11,364,281 - Dubowchik , et al. June 21, 2 | 2022-06-21 |
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
App 20220185856 - Morin; Paul E. ; et al. | 2022-06-16 |
Methods And Compositions For 18f-radiolabeling Of Biologics
App 20220184239 - DONNELLY; David | 2022-06-16 |
Antibody Heavy Chain Constant Domains
App 20220185877 - Stevens; Brenda L. ; et al. | 2022-06-16 |
Small Molecule Inhibitors Of Galectin-3
App 20220185800 - Liu; Chunjian ; et al. | 2022-06-16 |
Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors
App 20220185892 - KORMAN; Alan J. ; et al. | 2022-06-16 |
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
Grant 11,359,197 - Olson , et al. June 14, 2 | 2022-06-14 |
Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use
Grant 11,359,000 - Struthers , et al. June 14, 2 | 2022-06-14 |
Supramolecular high affinity protein-binding system for purification of biomacromolecules
Grant 11,359,005 - Cui , et al. June 14, 2 | 2022-06-14 |
Immunomodulators
Grant 11,358,988 - Gillman , et al. June 14, 2 | 2022-06-14 |
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof
App 20220177596 - YAMNIUK; Aaron ; et al. | 2022-06-09 |
Process For The Preparation Of N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide
App 20220177482 - Aytar; Burcu Selin ; et al. | 2022-06-09 |
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20220175921 - WANG; Changyu ; et al. | 2022-06-09 |
Classifying Documents Using A Domain-specific Natural Language Processing Model
App 20220179906 - DESAI; Sameen Mayur ; et al. | 2022-06-09 |
Cyclohexyl acid pyrazole azoles as LPA antagonists
Grant 11,352,345 - Shi , et al. June 7, 2 | 2022-06-07 |
Antibodies against CD73 and uses thereof
Grant 11,352,440 - Lonberg , et al. June 7, 2 | 2022-06-07 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 11,351,164 - Zhang , et al. June 7, 2 | 2022-06-07 |
TGF-beta inhibitors
Grant 11,352,360 - Kinsella , et al. June 7, 2 | 2022-06-07 |
Compositions and methods of treating cancer
Grant 11,351,163 - Basciano , et al. June 7, 2 | 2022-06-07 |
Amorphous And Crystalline Forms Of Ido Inhibitors
App 20220169615 - POWERS; Jay Patrick ; et al. | 2022-06-02 |
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof
App 20220169742 - YAMNIUK; Aaron ; et al. | 2022-06-02 |
PET imaging with PD-L1 binding polypeptides
Grant 11,344,639 - Morin , et al. May 31, 2 | 2022-05-31 |
High pH protein refolding methods
Grant 11,345,722 - Hollander , et al. May 31, 2 | 2022-05-31 |
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 11,345,752 - Lonberg , et al. May 31, 2 | 2022-05-31 |
Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators
App 20220162201 - Wacker; Dean A. ; et al. | 2022-05-26 |
Compositions And Methods Of Treating Cancer
App 20220160718 - Zhao; Qihong ; et al. | 2022-05-26 |
Additive Systems For Use In Protein Pegylation
App 20220160883 - Hickey; Matthew R. ; et al. | 2022-05-26 |
Use Of Low Ph And Dextran Sulfate During Harvest Treatment For Protein Purification
App 20220162260 - Tan; Zhijun ; et al. | 2022-05-26 |
Cyclic dinucleotides as anticancer agents
Grant 11,339,185 - Fink , et al. May 24, 2 | 2022-05-24 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 11,337,970 - Cherney , et al. May 24, 2 | 2022-05-24 |
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof
App 20220153856 - YAMNIUK; Aaron ; et al. | 2022-05-19 |
Cytokine Profiling Analysis
App 20220155320 - FARSACI; Benedetto | 2022-05-19 |
Synthetic process
Grant 11,332,442 - Gallagher , et al. May 17, 2 | 2022-05-17 |
Methods of treating colorectal cancer
Grant 11,332,529 - Axelson May 17, 2 | 2022-05-17 |
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof
App 20220144962 - YAMNIUK; Aaron ; et al. | 2022-05-12 |
Novel Synthetic Options Towards The Manufacture Of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-- 1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazol- O[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
App 20220144836 - CUNIERE; Nicolas ; et al. | 2022-05-12 |
Enhanced Performance Of Amorphous Solid And Solubilized Formulations For Achieving Therapeutic Plasma Concentrations
App 20220144835 - GARMISE; Robert J. ; et al. | 2022-05-12 |
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28
App 20220144951 - Valencia; Xavier ; et al. | 2022-05-12 |
Small Molecule Inhibitors Of Galectin-3
App 20220144818 - Liu; Chunjian ; et al. | 2022-05-12 |
Treatment Of Lung Cancer Using An Anti-fucosyl-gm1 Antibody
App 20220144967 - JACKSON; Jeffrey R. | 2022-05-12 |
Methods Of Isolating A Protein
App 20220135619 - FREY; Douglas D. ; et al. | 2022-05-05 |
Treatment Of Pd-l1-negative Melanoma Using An Anti-pd-1 Antibody And An Anti-ctla-4 Antibody
App 20220135685 - YANG; Arvin | 2022-05-05 |
Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators
App 20220135550 - WACKER; Dean A. ; et al. | 2022-05-05 |
Cyclohexyl acid triazole azoles as LPA antagonists
Grant 11,319,315 - Shi , et al. May 3, 2 | 2022-05-03 |
Cyclohexyl acid isoxazole azines as LPA antagonists
Grant 11,319,309 - Shi , et al. May 3, 2 | 2022-05-03 |
Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation
App 20220127233 - DELMONTE; Albert J. ; et al. | 2022-04-28 |
Use Of Anti-ctla-4 Antibodies With Enhanced Adcc To Enhance Immune Response To A Vaccine
App 20220127363 - LOFFREDO; John T. ; et al. | 2022-04-28 |
Human monoclonal antibodies that bind CXCR4 and uses thereof
Grant 11,312,777 - Kuhne , et al. April 26, 2 | 2022-04-26 |
Cyclohexyl acid pyrazole azines as LPA antagonists
Grant 11,312,706 - Shi , et al. April 26, 2 | 2022-04-26 |
Cyclic Dinucleotides As Anticancer Agents
App 20220117995 - FINK; Brian E. ; et al. | 2022-04-21 |
Fibronectin Based Scaffold Proteins Having Improved Stability
App 20220119495 - CAMPHAUSEN; Ray ; et al. | 2022-04-21 |
Triazolopyridinyl Compounds As Kinase Inhibitors
App 20220119388 - Luo; Guanglin ; et al. | 2022-04-21 |
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
Grant 11,306,150 - Johnston , et al. April 19, 2 | 2022-04-19 |
Anti-CD40 antibodies and uses thereof
Grant 11,306,149 - Barnhart , et al. April 19, 2 | 2022-04-19 |
Phenylacetamides as inhibitors of rock
Grant 11,306,081 - Orwat , et al. April 19, 2 | 2022-04-19 |
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
Grant 11,306,143 - Doyle , et al. April 19, 2 | 2022-04-19 |
Amino indole compounds useful as TLR inhibitors
Grant 11,306,092 - Dyckman , et al. April 19, 2 | 2022-04-19 |
Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-.alpha. modulators
Grant 11,299,494 - Weinstein , et al. April 12, 2 | 2022-04-12 |
Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
Grant 11,299,488 - Pinto , et al. April 12, 2 | 2022-04-12 |
Diazaindole compounds
Grant 11,299,501 - Dyckman , et al. April 12, 2 | 2022-04-12 |
Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment
Grant 11,299,543 - Farsaci , et al. April 12, 2 | 2022-04-12 |
Antibodies Comprising Modified Heavy Constant Regions
App 20220106400 - YAMNIUK; Aaron P. | 2022-04-07 |
Substituted tetrahydropyrrolo[1,2-a]pyrazines as alpha v integrin inhibitors
Grant 11,292,802 - Zhao , et al. April 5, 2 | 2022-04-05 |
Combination Of Dr5 Agonist And Anti-pd-1 Antagonist And Methods Of Use
App 20220098302 - BARNHART; Bryan ; et al. | 2022-03-31 |
Methods Of Analysis Using In-sample Calibration Curve By Multiple Isotopologue Reaction Monitoring
App 20220099637 - GU; Huidong ; et al. | 2022-03-31 |
Alkene spirocyclic compounds as farnesoid X receptor modulators
Grant 11,286,252 - Feng , et al. March 29, 2 | 2022-03-29 |
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
App 20220089734 - TIPTON; Kimberly Ann ; et al. | 2022-03-24 |
Antibodies Against Tim3 And Uses Thereof
App 20220089720 - SCHEBYE; Xiao Min ; et al. | 2022-03-24 |
Fibronectin binding domains with reduced immunogenicity
Grant 11,279,751 - Davis , et al. March 22, 2 | 2022-03-22 |
Substituted Amide Compounds Useful As Farnesoid X Receptor Modulators
App 20220081430 - Wacker; Dean A. ; et al. | 2022-03-17 |
Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
Grant 11,274,150 - Bezman , et al. March 15, 2 | 2022-03-15 |
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
Grant 11,274,152 - Korman , et al. March 15, 2 | 2022-03-15 |
Antibody Polypeptides That Antagonize Cd40l
App 20220073636 - NADLER; Steven G. ; et al. | 2022-03-10 |
Antibodies Binding to Vista at Acidic pH
App 20220073617 - Johnston; Robert J. ; et al. | 2022-03-10 |
Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
Grant 11,267,888 - Valencia , et al. March 8, 2 | 2022-03-08 |
Small molecule inhibitors of galectin-3
Grant 11,267,811 - Jalagam , et al. March 8, 2 | 2022-03-08 |
Cyclohexyl acid triazole azines as LPA antagonists
Grant 11,267,800 - Shi , et al. March 8, 2 | 2022-03-08 |
Process For The Preparation Of A Cyclic Dinucleotide
App 20220064205 - Schmidt; Michael Anthony ; et al. | 2022-03-03 |
Crystalline Forms Of A Par4 Inhibitor
App 20220064186 - Schlam; Roxana F. ; et al. | 2022-03-03 |
Substituted Thienopyrroles As Pad4 Inhibitors
App 20220064180 - Gardner; Daniel S. ; et al. | 2022-03-03 |
Cyclohexyl acid isoxazole azoles as LPA antagonists
Grant 11,261,180 - Cheng , et al. March 1, 2 | 2022-03-01 |
Pyrazole O-linked carbamoyl cyclohexyl acids as LPA antagonists
Grant 11,261,174 - Cheng , et al. March 1, 2 | 2022-03-01 |
Antagonistic CD40 monoclonal antibodies and uses thereof
Grant 11,261,258 - Yamniuk , et al. March 1, 2 | 2022-03-01 |
Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide
Grant 11,254,679 - Aytar , et al. February 22, 2 | 2022-02-22 |
Methods of treatment using IL-23p19 monoclonal antibodies
Grant 11,254,740 - Stevens , et al. February 22, 2 | 2022-02-22 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 11,253,525 - Balog , et al. February 22, 2 | 2022-02-22 |
Antagonistic CD40 monoclonal antibodies and uses in treating immune responses
Grant 11,254,750 - Yamniuk , et al. February 22, 2 | 2022-02-22 |
Substituted bicyclic compounds as farnesoid X receptor modulators
Grant 11,254,663 - Wacker , et al. February 22, 2 | 2022-02-22 |
Synthetic Process
App 20220048859 - Gallagher; William P. ; et al. | 2022-02-17 |
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
Grant 11,248,031 - Morin , et al. February 15, 2 | 2022-02-15 |
Methods Of Measuring Hydrophobicity Of Chromatographic Resins
App 20220042954 - HUANG; Chao ; et al. | 2022-02-10 |
Cycloheptyl Acids As Lpa Antagonists
App 20220041572 - Cheng; Peter Tai Wah ; et al. | 2022-02-10 |
Cyclopentyl Acids As Lpa Antagonists
App 20220041565 - Cheng; Peter Tai Wah ; et al. | 2022-02-10 |
Pyrimidinones As Factor Xia Inhibitors
App 20220041601 - Dilger; Andrew K. ; et al. | 2022-02-10 |
Methods Of Treating Tumor
App 20220041733 - LEI; Ming ; et al. | 2022-02-10 |
Antibodies against MICA and/or MICB and uses thereof
Grant 11,242,393 - Kuhne , et al. February 8, 2 | 2022-02-08 |
Antibodies Modified For Transglutaminase Conjugation, Conjugates Thereof, And Methods And Uses
App 20220031860 - STROP; Pavel ; et al. | 2022-02-03 |
Barcoded Peptide-mhc Complexes And Uses Thereof
App 20220034881 - Shah; Kalpit ; et al. | 2022-02-03 |
Amorphous and crystalline forms of IDO inhibitors
Grant 11,236,049 - Powers , et al. February 1, 2 | 2022-02-01 |
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
Grant 11,236,048 - Delmonte , et al. February 1, 2 | 2022-02-01 |
Classifying Pharmacovigilance Documents Using Image Analysis
App 20220027610 - DESAI; Sameen Mayur | 2022-01-27 |
Treatment Of Hodgkin Lymphoma Using An Anti-pd-1 Antibody
App 20220025049 - FARSACI; Benedetto | 2022-01-27 |
Devices And Systems For Delivery Of Combination Therapies
App 20220023531 - McLoughlin; Martin John ; et al. | 2022-01-27 |
Methods and compositions for 18F-radiolabeling of biologics
Grant 11,229,713 - Donnelly January 25, 2 | 2022-01-25 |
Treatment Of Lung Cancer Using A Combination Of An Anti-pd-1 Antibody And An Anti-ctla-4 Antibody
App 20220017619 - Nathan; Faith | 2022-01-20 |
Fgf-21 Conjugate Formulations
App 20220016211 - PALM; Thomas ; et al. | 2022-01-20 |
Antibodies Against Il-7r Alpha Subunit And Uses Thereof
App 20220017627 - Yamniuk; Aaron Paul ; et al. | 2022-01-20 |
Antibody Comprising A Glutamine-containing Light Chain C-terminal Extension, Conjugates Thereof, And Methods And Uses
App 20220016260 - STROP; Pavel ; et al. | 2022-01-20 |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
Grant 11,224,634 - Dubowchik , et al. January 18, 2 | 2022-01-18 |
Small Molecule Inhibitors Of Galectin-3
App 20220009913 - Swidorski; Jacob ; et al. | 2022-01-13 |
Treatment of C1013G/CXCR4-associated Waldenstrom's macroglobulinemia with an anti-CXCR4 antibody
Grant 11,220,548 - Ghobrial , et al. January 11, 2 | 2022-01-11 |
Process for preparing indole carboxamide compounds
Grant 11,220,489 - Fan , et al. January 11, 2 | 2022-01-11 |
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity
Grant 11,220,550 - Yamniuk , et al. January 11, 2 | 2022-01-11 |
Novel Pd-l1 Binding Polypeptides For Imaging
App 20220001040 - MORIN; Paul E. ; et al. | 2022-01-06 |
Pyrrolidinone Derivatives As Formyl Peptide 2 Receptor Agonists
App 20220002281 - WURTZ; Nicholas R. ; et al. | 2022-01-06 |
Treatment Of Renal Cell Carcinoma
App 20220002413 - SIMON; Jason Samuel ; et al. | 2022-01-06 |
Binding Molecules To The Human Ox40 Receptor
App 20220002428 - MIN; Jing ; et al. | 2022-01-06 |
Anti-trem-1 Antibodies And Uses Thereof
App 20220002404 - PASHINE; Achal ; et al. | 2022-01-06 |
Additive systems for use in protein PEGylation
Grant 11,213,589 - Hickey , et al. January 4, 2 | 2022-01-04 |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
Grant 11,213,586 - Wang , et al. January 4, 2 | 2022-01-04 |
Anti-ido Antibody And Uses Thereof
App 20210403602 - CHUNTHARAPAI; Anan ; et al. | 2021-12-30 |
Anti-trem-1 Antibodies And Uses Thereof
App 20210403561 - PASHINE; Achal ; et al. | 2021-12-30 |
Method Of Treating Lung Cancer
App 20210403569 - TSCHAIKA; Marina | 2021-12-30 |
Methods For The Selection Of Binding Proteins
App 20210403899 - LIPOVSEK; Dasa | 2021-12-30 |
Substituted Indole And Indazole Compounds
App 20210403468 - GILMORE; John L. ; et al. | 2021-12-30 |
Miniaturized Dystrophins And Uses Thereof
App 20210403947 - BANKS; Glen ; et al. | 2021-12-30 |
Anti-ICOS agonist antibodies and uses thereof
Grant 11,207,391 - Engelhardt , et al. December 28, 2 | 2021-12-28 |
Cytokine profiling analysis
Grant 11,209,441 - Farsaci December 28, 2 | 2021-12-28 |
Synthetic Processes For The Production Of 1-((3s,4r)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-3-pheny- Lurea
App 20210395200 - Ortiz; Adrian ; et al. | 2021-12-23 |
Anti-mertk Antibodies For Treating Cancer
App 20210395392 - Spires, Jr.; Thomas E. ; et al. | 2021-12-23 |
Substituted Indole Dimer Compounds
App 20210393608 - DYCKMAN; Alaric J. ; et al. | 2021-12-23 |
Serum albumin-binding fibronectin type III domains
Grant 11,203,630 - Mitchell , et al. December 21, 2 | 2021-12-21 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 11,203,592 - Seitz , et al. December 21, 2 | 2021-12-21 |
Handheld Medicament Dispenser
App 20210386626 - Pollack; Brandon J. ; et al. | 2021-12-16 |
Pet-imaging Immunomodulators
App 20210386876 - DONNELLY; David J. ; et al. | 2021-12-16 |
Camk2d Antisense Oligonucleotides And Uses Thereof
App 20210378652 - OLSON; Richard E. ; et al. | 2021-12-09 |
Radioligands For Imaging The Lpa1 Receptor
App 20210379210 - Cheng; Peter Tai Wah ; et al. | 2021-12-09 |
Methods Of Treating Tumor
App 20210380693 - MAIER; Sabine ; et al. | 2021-12-09 |
Multicyclic Compounds As Farnesoid X Receptor Modulators
App 20210380578 - Carpenter; Joseph E. ; et al. | 2021-12-09 |
Diazaspiro ROCK inhibitors
Grant 11,192,891 - Zhu , et al. December 7, 2 | 2021-12-07 |
Crystal Form Of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-- Yl)phenyl)amino)-n-(methyl-d3) Pyridazine-3-carboxamide
App 20210371404 - Zhang; Yanlei ; et al. | 2021-12-02 |
Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists
App 20210371378 - Shirude; Pravin Sudhakar ; et al. | 2021-12-02 |
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
Grant 11,186,544 - Wurtz , et al. November 30, 2 | 2021-11-30 |
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
Grant 11,185,570 - Dubowchik , et al. November 30, 2 | 2021-11-30 |
Combination Therapy Using An Anti-fucosyl-gm1 Antibody And An Anti-cd137 Antibody
App 20210363267 - CARDARELLI; Josephine M. ; et al. | 2021-11-25 |
Methods Of Treating Cancer With Antibodies Against Tim3
App 20210363242 - SCHEBYE; Xiao Min ; et al. | 2021-11-25 |
Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonists
Grant 11,180,488 - Cheng , et al. November 23, 2 | 2021-11-23 |
Antibody polypeptides that antagonize CD40L
Grant 11,180,567 - Nadler , et al. November 23, 2 | 2021-11-23 |
Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors
Grant 11,180,474 - Dyckman , et al. November 23, 2 | 2021-11-23 |
Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
Grant 11,180,490 - Smallheer , et al. November 23, 2 | 2021-11-23 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use
App 20210355113 - BALOG; James Aaron ; et al. | 2021-11-18 |
PD-L1 binding polypeptides for imaging
Grant 11,173,219 - Morin , et al. November 16, 2 | 2021-11-16 |
Alkene compounds as farnesoid x receptor modulators
Grant 11,168,079 - Carpenter , et al. November 9, 2 | 2021-11-09 |
Isofuranone compounds useful as HPK1 inhibitors
Grant 11,166,959 - Araujo , et al. November 9, 2 | 2021-11-09 |
Combination Therapy for Melanoma
App 20210338813 - MAURER; Matthew ; et al. | 2021-11-04 |
Compositions Comprising A Combination Of An Anti-lag-3 Antibody, A Pd-1 Pathway Inhibitor, And An Immunotherapeutic Agent
App 20210340250 - KORMAN; Alan J. ; et al. | 2021-11-04 |
Miniaturized Dystrophins Having Spectrin Fusion Domains and Uses Thereof
App 20210340195 - BANKS; Glen ; et al. | 2021-11-04 |
Benzofuran derivatives for the treatment of hepatitis C
Grant 11,161,837 - Yeung , et al. November 2, 2 | 2021-11-02 |
Fibronectin based scaffold proteins having improved stability
Grant 11,161,893 - Camphausen , et al. November 2, 2 | 2021-11-02 |
Genetic Polymorphisms Associated With Cardiovascular Disorders And Drug Response, Methods Of Detection And Uses Thereof
App 20210332434 - CARGILL; Michele ; et al. | 2021-10-28 |
Anti-TREM-1 antibodies and uses thereof
Grant 11,155,618 - Pashine , et al. October 26, 2 | 2021-10-26 |
Treatment Of Lung Cancer Using A Combination Of An Anti-pd-1 Antibody And Another Anti-cancer Agent
App 20210324106 - FELTQUATE; David ; et al. | 2021-10-21 |
Antibodies To Tigit
App 20210324072 - Maurer; Mark F. ; et al. | 2021-10-21 |
Imidazopyridazine Compounds
App 20210323966 - WEINSTEIN; David S. ; et al. | 2021-10-21 |
Tetrahydropyran-based Thiodisaccharide Mimics As Galectin-3 Inhibitors
App 20210323991 - Hartz; Richard A. ; et al. | 2021-10-21 |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
Grant 11,149,077 - Camphausen , et al. October 19, 2 | 2021-10-19 |
Oxabicyclo Acids As Lpa Antagonists
App 20210317131 - Cheng; Peter Tai Wah ; et al. | 2021-10-14 |
Indazole Carboxamides As Kinase Inhibitors
App 20210309633 - Guo; Junqing ; et al. | 2021-10-07 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use
App 20210299126 - BALOG; James Aaron ; et al. | 2021-09-30 |
Methods For Detecting Anti-drug Antibodies
App 20210302421 - XU; WEIFENG ; et al. | 2021-09-30 |
Protein Fragmentation Control Strategy By Re-oxidation In Downstream Chromatography
App 20210300964 - Tan; Zhijun ; et al. | 2021-09-30 |
Methods Of Treating A Tumor
App 20210292415 - CLEMENS; Wendy L. ; et al. | 2021-09-23 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use
App 20210290613 - CHERNEY; Emily Charlotte ; et al. | 2021-09-23 |
Dimethoxyphenyl Substituted Indole Compounds As Tlr7, Tlr8 Or Tlr9 Inhibitors
App 20210292300 - Dyckman; Alaric J. ; et al. | 2021-09-23 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use
App 20210283123 - ZHANG; Liping ; et al. | 2021-09-16 |
Compositions Comprising An Anti-lag-3 Antibody Or An Anti-lag-3 Antibody And An Anti-pd-1 Or Anti-pd-l1 Antibody
App 20210283251 - BURTON; Lori S. ; et al. | 2021-09-16 |
Fibronectin Based Scaffold Domain Proteins That Bind Pcsk9
App 20210277089 - CAMPHAUSEN; Ray ; et al. | 2021-09-09 |
Process For Preparing Indole Carboxamide Compounds
App 20210276970 - Fan; Junying ; et al. | 2021-09-09 |
Naphthyridinone Compounds Useful As T Cell Activators
App 20210277004 - Chupak; Louis S. ; et al. | 2021-09-09 |
Biaryl Kinase Inhibitors
App 20210277001 - Luo; Guanglin ; et al. | 2021-09-09 |
Ox-40 Agonist, Pd-1 Pathway Inhibitor And Ctla-4 Inhibitor Combination For Use In A Method Of Treating A Cancer Or A Solid Tumor
App 20210277135 - GAO; Chan ; et al. | 2021-09-09 |
Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators
App 20210261535 - Wacker; Dean A. ; et al. | 2021-08-26 |
Fgf-21 Formulations
App 20210260161 - PALM; Thomas ; et al. | 2021-08-26 |
Treatment Of Lag-3 Positive Tumors
App 20210261666 - NOVOTNY, JR.; James ; et al. | 2021-08-26 |
Single Pass Tangential Flow Filtration Hybrid Configurations For Enhancing Concentration Of Macromolecule Solutions
App 20210253633 - Arunkumar; Abhiram ; et al. | 2021-08-19 |
Substituted Indole Compounds
App 20210253593 - Dyckman; Alaric J. ; et al. | 2021-08-19 |
Methods Of Producing Recombinant Proteins
App 20210253996 - XU; Jianlin ; et al. | 2021-08-19 |
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
Grant 11021462 - | 2021-06-01 |
Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit
Grant 11020490 - | 2021-06-01 |
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
Grant 11021475 - | 2021-06-01 |
Immunotherapeutic Dosing Regimens Comprising Pomalidomide And An Anti-cs1 Antibody For Treating Cancer
App 20210154183A1 - | 2021-05-27 |
Spiroheptanyl Hydantoins As Rock Inhibitors
App 20210155618A1 - | 2021-05-27 |
Serially-connectable Drug Modules For Combinatorial Drug Delivery Device
App 20210154097A1 - | 2021-05-27 |
Anti-cd27 Antibodies And Uses Thereof
App 20210155703A1 - | 2021-05-27 |
Assay To Determine In Vivo Receptor Occupancy
App 20210156854A1 - | 2021-05-27 |
Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
Grant 11014922 - | 2021-05-25 |
Phenylacetamides As Inhibitors Of Rock
App 20210147407A1 - | 2021-05-20 |
Small Molecule Inhibitors Of Galectin-3
App 20210147408A1 - | 2021-05-20 |
Anticancer Combination Therapy With Cd73 Antagonist Antibody And Pd-1/pd-l1 Axis Antagonist Antibody
App 20210147570A1 - | 2021-05-20 |
5-membered And Bicyclic Heterocyclic Amides As Inhibitors Of Rock
App 20210147406A1 - | 2021-05-20 |
Apixaban Formulations
App 20210145817A1 - | 2021-05-20 |
Compounds Useful As Inhibitors Of Helios Protein
App 20210147383A1 - | 2021-05-20 |
Alkylphenyl Compounds
App 20210147357A1 - | 2021-05-20 |
Combinatorial Drug Delivery Device
App 20210145696A1 - | 2021-05-20 |
Oxime Ether Compounds
App 20210147361A1 - | 2021-05-20 |
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
Grant 11008300 - | 2021-05-18 |
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
Grant 11007180 - | 2021-05-18 |
Piperidinone formyl peptide 2 receptor agonists
Grant 11008301 - | 2021-05-18 |
Triazolopyridine inhibitors of myeloperoxidase and/or EPX
Grant 11008317 - | 2021-05-18 |
Quinazolines as potassium ion channel inhibitors
Grant 11008306 - | 2021-05-18 |
Antibodies against IL-7R alpha subunit and uses thereof
Grant 11008395 - | 2021-05-18 |
Antibodies to TIGIT
Grant 11008390 - | 2021-05-18 |
Imaging methods using 18F-radiolabeled biologics
Grant 10994033 - | 2021-05-04 |
Libraries of modified fibronectin type III tenth domain-containing polypeptides
Grant 10995131 - | 2021-05-04 |
Immunomodulators
Grant 10988507 - | 2021-04-27 |
Modified Self-immolating Moieties For Use In Prodrugs And Conjugates And Methods Of Using And Making
App 20210113706A1 - | 2021-04-22 |
Methods Of Treatment Using Ctla4 Molecules
App 20210115107A1 - | 2021-04-22 |
Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
Grant 10981879 - | 2021-04-20 |
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
Grant 10981914 - | 2021-04-20 |
Biaryl kinase inhibitors
Grant 10981910 - | 2021-04-20 |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
Grant 10982281 - | 2021-04-20 |
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
Grant 10983128 - | 2021-04-20 |
Modified Fibroblast Growth Factor 21 (fgf-21) For Use In Methods For Treating Nonalcoholic Steatohepatitis (nash)
App 20210106653A1 - | 2021-04-15 |
Indole Carboxamide Compounds
App 20210107891A1 - | 2021-04-15 |
Process For The Preparation Of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide
App 20210107897A1 - | 2021-04-15 |
Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same
Grant 10973768 - | 2021-04-13 |
Methods Of Treating Tumor
App 20210101980A1 - | 2021-04-08 |
Tricyclic sulfones as RORmodulators
Grant 10968177 - | 2021-04-06 |
3-substituted propionic acids as αV integrin inhibitors
Grant 10968219 - | 2021-04-06 |
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 10966967 - | 2021-04-06 |
TL1A antibodies and uses thereof
Grant 10968279 - | 2021-04-06 |
Compounds Useful As Immunomodulators
App 20210094932A1 - | 2021-04-01 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Grant 10959986 - | 2021-03-30 |
Selective NR2B antagonists
Grant 10961229 - | 2021-03-30 |
TGF beta receptor antagonists
Grant 10961239 - | 2021-03-30 |
Pyrazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists
App 20210087173A1 - | 2021-03-25 |
Aryl And Heteroaryl Substituted Indole Compounds
App 20210087174A1 - | 2021-03-25 |
[1,2,4]triazolo[1,5-a]pyridinyl Substituted Indole Compounds
App 20210085651A1 - | 2021-03-25 |
Cyclohexyl Acid Pyrazole Azines As Lpa Antagonists
App 20210087178A1 - | 2021-03-25 |
Selective NR2B antagonists
Grant 10954225 - | 2021-03-23 |
Substituted naphthyridinone compounds useful as T cell activators
Grant 10954238 - | 2021-03-23 |
Cyclic dinucleotides as anticancer agents
Grant 10953032 - | 2021-03-23 |
Bispecific EGFR/IGFIR binding molecules
Grant 10954286 - | 2021-03-23 |
Process For Preparing Tetrahydrocarbazole Carboxamide Compound
App 20210078980A1 - | 2021-03-18 |
Aryl Heterocyclic Piperidinone Formyl Peptide 2 Receptor And Formyl Peptide 1 Receptor Agonists
App 20210078971A1 - | 2021-03-18 |
Cyclohexyl Acid Pyrazole Azoles As Lpa Antagonists
App 20210078982A1 - | 2021-03-18 |
Non-chromatographic Purification Of Macrocyclic Peptides By A Resin Catch And Release
App 20210079046A1 - | 2021-03-18 |
Cyclic dinucleotides as anticancer agents
Grant 10947263 - | 2021-03-16 |
Methods of purifying proteins
Grant 10947268 - | 2021-03-16 |
Fibronectin based scaffold domain proteins that bind PCSK9
Grant 10947297 - | 2021-03-16 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use
App 20210070698A1 - | 2021-03-11 |
Substituted Indole Ether Compounds
App 20210070751A1 - | 2021-03-11 |
Fibronectin Type Iii Domain Proteins With Enhanced Solubility
App 20210070840A1 - | 2021-03-11 |
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
Grant 10941145 - | 2021-03-09 |
Carbohydrate content of CTLA4 molecules
Grant 10941189 - | 2021-03-09 |
Substituted Pyridopyrimidinonyl Compounds Useful As T Cell Activators
App 20210061802A1 - | 2021-03-04 |
Methods And Compositions For Deuterated Biologics
App 20210060184A1 - | 2021-03-04 |
Serum albumin binding molecules
Grant 10934572 - | 2021-03-02 |
Heterocyclic sulfones as ROR gamma modulators
Grant 10934286 - | 2021-03-02 |
Macrocyclic Toll-like Receptor 7 (tlr7) Agonists
App 20210053979A1 - | 2021-02-25 |
Compounds Useful As Immunomodulators
App 20210053972A1 - | 2021-02-25 |
Use Of Caprylic Acid Precipitation For Protein Purification
App 20210054024A1 - | 2021-02-25 |
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof
App 20210054090A1 - | 2021-02-25 |
Combination Therapy With Anti-il-8 Antibodies And Anti-pd-1 Antibodies For Treating Cancer
App 20210054063A1 - | 2021-02-25 |
Antibodies To Cd40
App 20210054091A1 - | 2021-02-25 |
Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer
Grant 10925867 - | 2021-02-23 |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
Grant 10927114 - | 2021-02-23 |
Compositions Monovalent For Cd28 Binding And Methods Of Use
App 20210047414A1 - | 2021-02-18 |
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
Grant 10919895 - | 2021-02-16 |
Compositions monovalent for CD28 binding and methods of use
Grant 10919965 - | 2021-02-16 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20210040181A1 - | 2021-02-11 |
Aminotriazolopyridines as kinase inhibitors
Grant 10913738 - | 2021-02-09 |
[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
Grant 10912766 - | 2021-02-09 |
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
Grant 10913741 - | 2021-02-09 |
Heterocyclic Compounds Comprising Pyridine Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses
App 20210032220A1 - | 2021-02-04 |
Compositions And Methods Of Treating Cancer
App 20210030739A1 - | 2021-02-04 |
Methods Of Treating Tumor
App 20210032344A1 - | 2021-02-04 |
Substituted 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazines as factor xia inhibitors
Grant 10906886 - | 2021-02-02 |
Real-time Monitoring Of Protein Concentration Using Ultraviolet Signal
App 20210024873A1 - | 2021-01-28 |
Method Of Purity Determination By Capillary Electrophoresis
App 20210025847A1 - | 2021-01-28 |
Substituted glycine derived FXIA inhibitors
Grant 10899743 - | 2021-01-26 |
Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
Grant 10899745 - | 2021-01-26 |
Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making
Grant 10898578 - | 2021-01-26 |
| 